News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Pablo Mando: Honored and Privileged to Have Been Part of the Faculty of BCY at ESMO Breast 2025
Pablo Mando/X
May 18, 2025, 11:12

Pablo Mando: Honored and Privileged to Have Been Part of the Faculty of BCY at ESMO Breast 2025

Pablo Mando, Clinical Oncologist at CEMIC, Buenos Aires, Argentina, shared a post on X:

“It’s been an honor and privilege to have been part of the faculty of BCY at ESMO Breast 2025. A growing community working for the young patients with BC. Thank you, Matteo Lambertini and Dr Paluch-Shimon.”

More posts featuring Pablo Mando.

cancer ESMO Breast 2025 Matteo Lambertini OncoDaily Oncology pablo mando Paluch-Shimon
Special Coverage
Blog
Jul 4, 2025, 03:59
How widely is PET imaging used in brain tumour care across Europe? - EORTC
Blog
Jul 4, 2025, 03:32
The Impact Report of the European Week Against Cancer 2025 is live - Association of European Cancer Leagues
Science
Jul 4, 2025, 03:04
Herbert Loong: The Prevalence and Prognostic Impact of Comorbidities and Bloodindices in Sarcomas
Blog
Jul 4, 2025, 03:00
The Launch of Australia's National Lung Cancer Screening Program - Lung Cancer Policy Network
Blog
Jul 4, 2025, 02:48
Tom Powles: Axel Bex Discussing the Role of Partial Nephrectomy in Renal Cancer
Blog
Jul 4, 2025, 02:47
Filipe Coutinho: A Pilot Educational Intervention to Bring the Principles of Geriatric Oncology into Undergraduate Medical Training
Blog
Jul 4, 2025, 02:43
Advocates from Lung Cancer Europe Member Organisations at the WECAN Academy 2025
Blog
Jul 4, 2025, 02:37
Shining a Light on a Rare But Life-altering Disease: Bone Cancer - Medicaid Cancer Foundation
Opinion
Jul 4, 2025, 02:12
Yüksel Ürün: As an ASCO Leadership Development Program Graduate, This Program Changes Lives
Oncolibrary
Jul 4, 2025, 02:05
ESMO GI 2025 Highlights: MATTERHORN Trial on Durvalumab + FLOT in Resectable G/GEJ Adenocarcinoma
Oncolibrary
Jul 4, 2025, 01:11
Common Side Effects of Oral Chemotherapy and How to Manage Them
Insight
Jul 3, 2025, 17:51
Maximilian Merz: How to Train Your Virtual Twin with 10 Million Euros